Scitech to attend SNMMI Annual Meeting in Toronto

We are excited to attend the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in Toronto from June 8-11. Recognised as the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging, this meeting provides a unique platform to showcase Scitech’s expertise in the field.

Leading radiopharmaceutical expertise

Our subject matter experts are skilled at working with companies to develop or expand their nuclear medicine facilities, leveraging two decades of experience to manage the varied complexities of these projects. Our teams provide consultancy services and deliver full lifecycle projects for clients worldwide, with experience covering all stages of design and engineering services, from early strategic and technical advice to construction, qualification and validation, and regulatory compliance.

Over the course of four days, the SNMMI Annual Conference will offer attendees, including physicians, technologists, pharmacists, laboratory professionals, and scientists, a comprehensive exploration of the latest research and developments in nuclear medicine and molecular imaging. Moreover, it will delve into practical applications tailored for clinical settings, ensuring a well-rounded understanding of the industry’s advancements.

Showcasing radiopharmaceutical facility design

Representing Scitech at the event will be Dave Grant, Managing Director of Scitech Ltd; Marlous van der Hooft, Managing Director of Scitech GmbH; and Mark Randle, Scitech Sales Manager. They will showcase Scitech’s 20 years of continuous experience delivering a wide range of radiopharmaceutical projects.

Dave Grant commented: “The advancements in nuclear medicine and molecular imaging hold immense promise. These current strides are laying the foundation for improved diagnostics and more precisely targeted therapies, offering a brighter outlook for patient well-being. As we look to the future, we anticipate even more innovative applications and breakthroughs that will transform how we understand and treat various medical conditions. It is an exciting time to be part of this field, and we are committed to contributing to its growth and development.”

For more information about Scitech’s radiopharmaceutical services or to schedule a meeting with our experts at the SNMMI Annual Meeting, please visit our website or contact Dave, Marlous, or Mark. You can find us at booth 1930.

Get in touch